Spain has vaccinated 33.4 million people with at least the first dose of the vaccine, more than 70% (70.4) of the population. Communities have exceeded that percentage this Friday after administering a total of 566,184 doses of any of the available vaccines against COVID-19 during the weekend.
Third dose in residences? Outbreaks in senior centers push to seek alternatives to isolation
In total, the communities have already given 59,108,679 doses since the start of the campaign, in December 2020, and 28.6 million people already have the full schedule, more than 60% (60.2) of the population. With this, the country is approaching the goal set by the Government of immunizing 70% of the population before the end of the summer.
Precisely this monday Health has begun to distribute 2.8 million doses among the autonomous communities. The arrival of the extra batch of vaccines will allow increasing the doses administered this August from 16 to 19 million, with which the Government believes that it will be able to advance, “even a few days”, its purpose of achieving that 70% of the population be immunized at the end of August.
Of those 2.8 million, 1.1 correspond to the 3.4 million extra that Pfizer assured that it would deliver during August. In the next few days, 913,000 doses of Moderna will also arrive.
By age group, 92.9% of those over 40 years of age have at least one dose and 89.6% have received the complete vaccination schedule necessary to achieve maximum immunity. All those over 80 have been fully immunized since May and almost all those over 60 have also received the full guideline.
92.3% of the 50-59 group received the first puncture and 88.9% of that age group received the complete pattern. Of the next group, those from 40 to 49, 83.9% have the first pattern and 79.4% the maximum immunity.
Vaccination of those under 30 years of age, precisely those with the worst incidence data in this second wave, also continues to advance. 60.3% have received the first dose and 23% have the complete schedule among young people aged 20 to 29, while among the next group (12 to 19) 25.5% have a first dose and only 4 , 8% have received the double standard.
RNA vaccines driven by the pandemic open a “revolution” against diseases such as malaria or AIDS
With the global crisis due to the COVID-19 pandemic, a biotechnology race has been witnessed to obtain a vaccine against the coronavirus in the shortest possible time. This effort of world scientific knowledge has been the necessary impetus for the application of a type of technology that may mean the future for vaccines and treatments of different diseases: messenger RNA (mRNA).
Although it is too early to know exactly, vaccines based on this technology “are going to be a revolution. They have already done it with COVID-19, and the people who have developed this vaccination technology are clear candidates for the Nobel Prize,” he says. Raúl Rivas, professor of Microbiology and scientific communicator.